Skip to main content
search
All Posts By

admin

External Affairs Working PartyExternal Affairs Working Party Archive

External Affairs WP Minutes – 18 February 2022

The BIVDA External Affairs Working Party held its latest meeting on Friday 18 February. The group were joined by guest speaker Alexandra Hammond, Head of Sustainable Procurement and Supply Chain at NHS England on the subjects of NHS sustainability targets, the Evergreen Supplier Assessment and PPN 06/20. Doris-Ann also presented on the latest updates on BIVDA activity, including meetings with…
admin
February 25, 2022
Consultations Archive

Call for evidence on the 10-year Cancer Plan

DHSC have opened a call for evidence to aid in development of their 10-year Cancer Plan in England. The aim of this is to improve diagnosis and treatment of cancers. The following topics are covered within the survey: Cancer signs and symptoms, and the existing knowledge in this space Access to information Treatment Priorities (and what the respondent believes these…
admin
February 18, 2022
Consultations Archive

Supplier PPN 06/21 and NHS Requirements Readiness – NHS England and NHS Improvement

Supplier PPN 06/21 Readiness Feedback - NHS England and NHS Improvement (office.com) NHS England’s position on what to ask suppliers for is under consideration and the wording that was in the survey previously didn’t reflect this and has been updated. They are seeking supplier feedback on Scope 1 and 2 emissions. Suppliers have until the 28 February 2022 at 5pm…
admin
February 18, 2022
Consultations Archive

New Proposals on the future of UK Clinical Trial Legislation

The Medicines and Healthcare products Regulatory Agency (MHRA) have published a consultation on proposals for legislative changes for clinical trials. The consultation aims to amend the existing requirements for clinical trials in the UK, regulated by the Medicines for Human Use (Clinical Trials) Regulations 2004, as amended. Any amendments are intended to streamline approval of clinical trials, enable innovation, enhance…
admin
February 18, 2022
HighlightsHighlights Archive

Introduction to the Infection Management Coalition White Paper

The Covid-19 pandemic has made people more conscious of their personal health than ever before and has created awareness of the devastating impact that infections can have. Indeed, those living with supressed immune systems may have already been far more aware of the fatal risks posed by infection. We have all now witnessed how our individual actions can impact the…
admin
February 11, 2022
Membership NewsMembership News Archive

UK Health Security Agency, strategy and collaboration

BIVDA now has over 200 members from the IVD industry and can confidently liaise with stakeholders as the voice of the industry. We are in a unique position in being the representative Association for around 95% of IVD companies operating in the UK. The structure of our membership spans across spin outs and start-ups, through to multi-nationals across all disciplines,…
admin
February 11, 2022
HighlightsHighlights Archive

Media Monitoring: 4/2 – 11/2

US research director appointed first chief executive of Advanced Research and Invention Agency Dr Peter Highnam to head up the Advanced Research and Invention Agency (ARIA) as its first CEO Backed by £800 million, it will empower exceptional scientists to focus on high-risk projects at the frontier of discovery and innovation that could transform people’s lives for the better, maintaining…
admin
February 11, 2022
Close Menu